JP2022546539A5 - - Google Patents
Info
- Publication number
- JP2022546539A5 JP2022546539A5 JP2022514014A JP2022514014A JP2022546539A5 JP 2022546539 A5 JP2022546539 A5 JP 2022546539A5 JP 2022514014 A JP2022514014 A JP 2022514014A JP 2022514014 A JP2022514014 A JP 2022514014A JP 2022546539 A5 JP2022546539 A5 JP 2022546539A5
- Authority
- JP
- Japan
- Prior art keywords
- myxv
- myxoma virus
- activity
- protein
- reduce
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962894925P | 2019-09-02 | 2019-09-02 | |
| US62/894,925 | 2019-09-02 | ||
| US201962944233P | 2019-12-05 | 2019-12-05 | |
| US62/944,233 | 2019-12-05 | ||
| PCT/US2020/049061 WO2021046125A1 (en) | 2019-09-02 | 2020-09-02 | A new oncolytic virus platform to treat cancers with myxoma virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022546539A JP2022546539A (ja) | 2022-11-04 |
| JP2022546539A5 true JP2022546539A5 (https=) | 2023-09-08 |
Family
ID=74681244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022514014A Pending JP2022546539A (ja) | 2019-09-02 | 2020-09-02 | 粘液腫ウイルスを用いて癌を治療するための新しい腫瘍崩壊ウイルスプラットフォーム |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11117934B2 (https=) |
| EP (1) | EP4025228A4 (https=) |
| JP (1) | JP2022546539A (https=) |
| KR (1) | KR20220112241A (https=) |
| CN (1) | CN114615988A (https=) |
| AU (1) | AU2020342510A1 (https=) |
| CA (1) | CA3152779A1 (https=) |
| IL (1) | IL291009A (https=) |
| MX (1) | MX2022002547A (https=) |
| TW (1) | TW202122411A (https=) |
| WO (1) | WO2021046125A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210031485A (ko) * | 2018-07-13 | 2021-03-19 | 아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 | Tnf를 발현하는 점액종 바이러스로 암을 치료하는 방법 |
| CA3112788A1 (en) * | 2018-09-05 | 2020-03-12 | Arizona Board Of Regents On Behalf Of Arizona State University | Oncolytic virus platform to treat hematological cancer |
| EP3946373A4 (en) * | 2019-03-28 | 2023-01-11 | Arizona Board of Regents, a Body Corporate of the State of Arizona, acting for and on behalf of Arizona State University | ONCOLYTIC MYXOMA VIRUS EXPRESSING FAST P14 FOR TREATING BLOOD CANCER |
| TW202122411A (zh) | 2019-09-02 | 2021-06-16 | 美國亞利桑那州立大學亞利桑那州評議委員會 | 以黏液瘤(myxoma)病毒治療癌症之新穎溶瘤病毒平臺 |
| US20230372472A1 (en) * | 2020-09-25 | 2023-11-23 | President And Fellows Of Harvard College | Immunotherapeutic virus for the treatment of cancer |
| JP2024508920A (ja) * | 2021-03-01 | 2024-02-28 | オンコミクス セラピューティクス，インク． | 多武装の粘液腫ウイルス |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2153284B1 (es) * | 1998-06-10 | 2001-09-01 | Fundacion Para El Estudio Y De | Nuevo virus recombinante de mixoma atenuado y su uso en la preparacion de vacunas mixtas contra la mixomatosis y la enfermedad hemorragica de los conejos. |
| KR100747646B1 (ko) | 2005-02-25 | 2007-08-08 | 연세대학교 산학협력단 | 데코린 유전자를 포함하는 유전자 전달 시스템 및 이를 포함하는 약제학적 항종양 조성물 |
| WO2007143545A2 (en) * | 2006-06-01 | 2007-12-13 | Robarts Research Institute | Tnf signaling in myxoma virus treatments |
| WO2008134879A1 (en) | 2007-05-04 | 2008-11-13 | University Health Network | Il-12 immunotherapy for cancer |
| FR2946536B1 (fr) * | 2009-06-11 | 2011-07-29 | Agronomique Inst Nat Rech | Utilisation d'une souche attenuee de myxoma virus comme oncolytique |
| JP2013531496A (ja) * | 2010-06-06 | 2013-08-08 | モウント シナイ スクール オフ メディシネ | 組換えｒｎａウイルス及びその使用 |
| ES2733211T3 (es) * | 2011-04-15 | 2019-11-28 | Genelux Corp | Cepas clonales de virus vaccinia atenuados y métodos de uso de las mismas |
| WO2012171007A2 (en) | 2011-06-09 | 2012-12-13 | University Of Florida Research Foundation, Inc. | Methods for treating or preventing graft versus host disease |
| UA127337C2 (uk) | 2013-11-28 | 2023-07-26 | Баваріан Нордік А/С | Рекомбінантний поксвірус для індукції посиленої імунної відповіді та його застосування |
| KR20160140075A (ko) | 2015-05-29 | 2016-12-07 | 코오롱생명과학 주식회사 | 폭스바이러스 유래 프로모터 및 이를 포함하는 벡터 |
| JP6827467B2 (ja) * | 2015-06-19 | 2021-02-10 | シルラジェン，インコーポレイテッド | ウイルス塞栓術のための組成物および方法 |
| EP3402498A1 (en) | 2016-01-11 | 2018-11-21 | Synlogic, Inc. | Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells |
| JP2019527737A (ja) * | 2016-08-09 | 2019-10-03 | アルケヤール， アルモハナッドＡＬＫＡＹＹＡＬ， Ａｌｍｏｈａｎａｄ | Ｉｌ１２を発現する腫瘍溶解性ラブドウイルス |
| CN110418648B (zh) | 2017-02-22 | 2023-09-08 | 丁恩雨 | 一种编码人GM-CSF与多串连表位融合的mRNA癌症疫苗 |
| KR20210031485A (ko) | 2018-07-13 | 2021-03-19 | 아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 | Tnf를 발현하는 점액종 바이러스로 암을 치료하는 방법 |
| EP3833367A4 (en) | 2018-08-08 | 2022-05-11 | Arizona Board of Regents on behalf of Arizona State University | Method for improved poxvirus yields |
| MX2021001883A (es) | 2018-08-16 | 2021-07-15 | Musc Found For Res Dev | Virus recombinantes del mixoma y usos de los mismos. |
| CA3112788A1 (en) | 2018-09-05 | 2020-03-12 | Arizona Board Of Regents On Behalf Of Arizona State University | Oncolytic virus platform to treat hematological cancer |
| EP3946373A4 (en) | 2019-03-28 | 2023-01-11 | Arizona Board of Regents, a Body Corporate of the State of Arizona, acting for and on behalf of Arizona State University | ONCOLYTIC MYXOMA VIRUS EXPRESSING FAST P14 FOR TREATING BLOOD CANCER |
| JP2022546985A (ja) | 2019-09-02 | 2022-11-10 | アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・アリゾナ・ステイト・ユニバーシティー | 非許容性の癌に対する腫瘍溶解性ウイルスの感染を改善する方法および組成物 |
| TW202122411A (zh) | 2019-09-02 | 2021-06-16 | 美國亞利桑那州立大學亞利桑那州評議委員會 | 以黏液瘤(myxoma)病毒治療癌症之新穎溶瘤病毒平臺 |
| JP2024508920A (ja) | 2021-03-01 | 2024-02-28 | オンコミクス セラピューティクス，インク． | 多武装の粘液腫ウイルス |
-
2020
- 2020-09-02 TW TW109130086A patent/TW202122411A/zh unknown
- 2020-09-02 US US17/010,711 patent/US11117934B2/en active Active
- 2020-09-02 JP JP2022514014A patent/JP2022546539A/ja active Pending
- 2020-09-02 CA CA3152779A patent/CA3152779A1/en active Pending
- 2020-09-02 MX MX2022002547A patent/MX2022002547A/es unknown
- 2020-09-02 CN CN202080076788.8A patent/CN114615988A/zh active Pending
- 2020-09-02 WO PCT/US2020/049061 patent/WO2021046125A1/en not_active Ceased
- 2020-09-02 AU AU2020342510A patent/AU2020342510A1/en not_active Abandoned
- 2020-09-02 KR KR1020227010537A patent/KR20220112241A/ko not_active Ceased
- 2020-09-02 EP EP20861091.5A patent/EP4025228A4/en active Pending
-
2021
- 2021-06-24 US US17/357,624 patent/US20210324014A1/en not_active Abandoned
-
2022
- 2022-03-01 IL IL291009A patent/IL291009A/en unknown
- 2022-08-22 US US17/893,052 patent/US12331079B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022546539A5 (https=) | ||
| JP2023134519A5 (https=) | ||
| JP2022543009A5 (https=) | ||
| JP2023113641A5 (https=) | ||
| CR20210578A (es) | Derivados de ácido itacónico y usos de estos en el tratamiento de una enfermedad inflamatoria asociada con una respuesta inmunotaria indeseable | |
| JP2024156852A5 (https=) | ||
| JP2019058014A5 (https=) | ||
| JP2014513036A5 (https=) | ||
| MX2010009563A (es) | Compuestos quimicos con accion antiviral contra virus de dengue y otros flavivirus. | |
| JP2025023938A5 (https=) | ||
| JP2018184433A5 (https=) | ||
| JP2016510130A5 (https=) | ||
| JP2022540353A5 (https=) | ||
| JP2022538215A5 (https=) | ||
| JP2025106258A5 (https=) | ||
| JP2018117620A5 (https=) | ||
| JP2025118771A5 (https=) | ||
| JP2018504468A5 (https=) | ||
| JP2025038009A5 (https=) | ||
| JP2023139025A5 (https=) | ||
| JP2018037906A5 (https=) | ||
| JP2022532048A5 (https=) | ||
| JP2024038101A5 (https=) | ||
| JP2011510778A5 (https=) | ||
| JP2023508938A5 (https=) |